CardioKinetix

Menlo Park, United States Founded: 2003 • Age: 23 yrs
Develops implants for treating heart failure.

About CardioKinetix

CardioKinetix was a Healthcare company based in Menlo Park (United States) founded in 2003. It develops implants for treating heart failure. It operates on a B2B model. CardioKinetix has raised $137.06 million across 4 funding rounds from investors including J P Morgan, Lexington Partners and Edwards Lifesciences. The company has 23 employees. The company is recorded as dissolved. Its focus areas include Medical Devices, Cardiology and Heart Implants. Its legal entity is CARDIOKINETIX INC. Its competitors include CVRx, HeartWare and Element Science; 3 of its 3 listed competitors have raised funding.

Company details

CardioKinetix, established in 2003, excels in providing healthcare solutions, developing medical devices, cardiology, and heart implants. Develops implants for treating heart failure. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.

  • Headquarters Menlo Park, United States
  • Employees 23
  • Sectors
    Healthcare
  • Website cardiokinetix.com
  • Social X
  • Legal Name Cardiokinetix Inc
Key Metrics
  • Total Equity Funding
    $137.06M (USD)

    in 4 rounds

  • Latest Funding Round
    $50M (USD), Series F

    Dec 2014

  • Investors
    J P Morgan

    & 8 more

  • Employee Count
    23

Funding Insights of CardioKinetix

CardioKinetix has successfully raised a total of $137.06M across 4 strategic funding rounds. The most recent funding activity was a Series F round of $50 million completed in December 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $137.06M
  • Total Rounds 4
  • Last Round Series F β€” $50M
  • First Round $14.5M

    (Jul 2008)

  • Investors Count 9

All 4 funding rounds of CardioKinetix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2014$50MSeries F–Edwards Lifesciences
Feb 2013$48MSeries E––
Sep 2011$24.56MSeries C––
–
Jul 2008$14.5MSeries C––
Valuation history

9 investors in total: 9 institutional.

Investors in CardioKinetix

CardioKinetix has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include J P Morgan, Lexington Partners and Edwards Lifesciences.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Early & later stage venture capital firm investing in the US
panoramacapital.comCampbell, United States
Stage-agnostic investments in US life sciences are managed.
2005nlvpartners.comNew York, United States
Secondary private equity and co-investments are managed diversely.
1994lexingtonpartners.comNew York, United States
VC firm that focuses on early stage investments in the US
usvp.comMenlo Park, United States
Venture capital fund focused on early-stage healthcare startups
svhealthinvestors.comBoston, United States
US healthcare companies are invested in stage-agnostically by Cutlass Capital.
cutlasscapital.comBoston, United States
Medical devices for structural heart disease are developed and provided.
1958edwards.comIrvine, United States
Investment advisory services are provided to financial clients.
1986teklacap.comBoston, United States
Comprehensive financial services are provided to corporations and individuals.
1799jpmorgan.comNew York, United States
Premium access

Investor details for CardioKinetix

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of CardioKinetix

1 people are tracked at CardioKinetix (1 in leadership); the tracked headcount is 23.

NameRoleGroup
Maria Sainz
President and CEOLeadership
Premium access

Complete people profiles for CardioKinetix

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of CardioKinetix

3 dated milestones of CardioKinetix across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded CardioKinetix is founded.
  2. Funding First funding round of $14.5M.
  3. Funding Latest funding round, Series F, of $50.0M.

Competitors of CardioKinetix

CardioKinetix has 3 listed competitors in our database, 3 of them funded. They include CVRx, HeartWare and Element Science.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
cvrx.com2001Minneapolis, United States$368.5M142
Implantable technology for hypertension and heart failure is developed.
heartware.com2005Framingham, United States$12.38M547
Miniaturized ventricular assist devices are developed for heart failure treatment.
elementscience.com2013San Francisco, United States$192.6M
Wearable patch defibrillators are developed for sudden cardiac arrest treatment.
Premium access

Detailed competitors of CardioKinetix

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of CardioKinetix

Websites that share an audience with CardioKinetix (cardiokinetix.com).

Similar websites

Websites whose visitors overlap most with CardioKinetix. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
atricure.com
83%
18.2K#1,529,838View details

Top companies in Cardiac and Vascular Disorders

3 companies that operate in the same segment as CardioKinetix (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Gene-editing therapies for coronary artery disease are developed.
2018Cambridge, Massachusetts, United StatesUSD 215.5 M255
Cardiac monitoring devices and applications are provided for heart health.
2010Mountain View, California, United StatesUSD 114.38 MUSD 6.18 M67
Therapies for lowering low-density lipoprotein cholesterol levels are developed.
1998Ann Arbor, Michigan, United StatesUSD 129.7 MUSD 332.31 M304
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Cardiokinetix

Premium access

Complete news archive for CardioKinetix

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about CardioKinetix

CardioKinetix was founded in 2003 and raised its 1st funding round 5 years after it was founded.

CardioKinetix is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.

CardioKinetix is a funded company, having raised a total of $137.06M across 4 funding rounds to date. The company's 1st funding round was a Series C of $14.5M, raised on Jul 2008.

CardioKinetix has 23 employees.

CardioKinetix, established in 2003, excels in providing healthcare solutions, developing medical devices, cardiology, and heart implants. Develops implants for treating heart failure. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.

CardioKinetix's top competitors include CVRx, Element Science and HeartWare.

CardioKinetix has 9 investors. Key investors include J P Morgan, Lexington Partners, Edwards Lifesciences, New Leaf Venture Partners, and Tekla Capital Management.

CardioKinetix operates through Cardiokinetix Inc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available